ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Characterizing Inflammatory Phenotypes Associated with RUNX1 Deficiency | Dana-Farber Cancer Institute / Waihay Wong, MD/PhD | RUNX1 Early Career Investigator Grants | 2021 | Massachusetts |
Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders | The Regents of the University of California San Francisco / Serine Avagyan, MD/PhD | RUNX1 Early Career Investigator Grants | 2021 | California |
Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants | University of Washington, Seattle / Abbye McEwen, MD, PhD | RUNX1 Early Career Investigator Grants | 2022 | Washington |
Creating an Infrastructure for Collaborative Clinical Research and Publication of Consensus Guidelines for RUNX1 Familial Platelet Disorder | The Cleveland Clinic Foundation / Brittany Stewart, PhD | RUNX1 Early Career Investigator Grants | 2023 | Ohio |
Empowering specificity of AML immunotherapies by HSC engineering | Boston Children’s Hospital / Pietro Genovese | Catalyst Grants | 2023 | Massachusetts |
A Genomics Driven Pluripotent Stem Cell Model of Infant Lymphoblastic Leukemia | Children's Mercy Hospital Kansas City / Meagan Vacek, DO | Catalyst Grants | 2023 | Missouri |
Targeting Spinal Ependymoma and Other Gliomas Using Novel Genetically Defined Models | The Johns Hopkins University School of Medicine / Charles Eberhart, MD, PhD | Catalyst Grants | 2019 | Maryland |
Empowering specificity of AML immunotherapies by HSC engineering | Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Pietro Genovese | Catalyst Grants | 2023 | Georgia |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma | Board of Trustees of the Leland Stanford Junior University / Michelle Monje | Catalyst Grants | 2021 | California |
Cell Line and Xenograft Repository | Texas Tech University Health Sciences Center / Patrick Reynolds, MD/PhD | Catalyst Grants | 2014 | Texas |